Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Antiangiogenic Effect of TW37, a Small-Molecule Inhibitor of Bcl-2

Cancer Res (2006) 66 (17): 8698–8706.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor
  • Meghana Manjunath
  • Sai Swaroop
  • Sai Sanwid Pradhan
  • Raksha Rao K
  • Raghunandan Mahadeva
  • Venketesh Sivaramakrishnan
  • Bibha Choudhary
Genes (2022) 13 (7): 1208.
KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease
  • Yutaro Mori
  • Amrendra K. Ajay
  • Jae-Hyung Chang
  • Shan Mou
  • Huiping Zhao
  • Seiji Kishi
  • Jiahua Li
  • Craig R. Brooks
  • Sheng Xiao
  • Heung-Myong Woo
  • Venkata S. Sabbisetti
  • Suetonia C. Palmer
  • Pierre Galichon
  • Li Li
  • Joel M. Henderson
  • Vijay K. Kuchroo
  • Julie Hawkins
  • Takaharu Ichimura
  • Joseph V. Bonventre
Cell Metabolism (2021) 33 (5): 1042.
B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy
  • Manzar Alam
  • Sabeeha Ali
  • Taj Mohammad
  • Gulam Mustafa Hasan
  • Dharmendra Kumar Yadav
  • Md. Imtaiyaz Hassan
International Journal of Molecular Sciences (2021) 22 (19): 10442.
Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery
  • Ling-Ling Yang
  • Hua-Li Wang
  • Yu-Hang Yan
  • Sha Liu
  • Zhu-Jun Yu
  • Meng-Yi Huang
  • Yubin Luo
  • Xi Zheng
  • Yamei Yu
  • Guo-Bo Li
European Journal of Medicinal Chemistry (2020) 192: 112201.
A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways
  • Shi-Jun Yue
  • Peng-Xuan Zhang
  • Yue Zhu
  • Nian-Guang Li
  • Yan-Yan Chen
  • Jia-Jia Li
  • Sai Zhang
  • Ru-Yi Jin
  • Hao Yan
  • Xu-Qin Shi
  • Yu-Ping Tang
  • Jin-Ao Duan
Molecules (2019) 24 (11): 2165.
Importance of Hypericin-Bcl2 interactions for biological effects at subcellular levels
  • Katarina Stroffekova
  • Silvia Tomkova
  • Veronika Huntosova
  • Tibor Kozar
Photodiagnosis and Photodynamic Therapy (2019) 28: 38.
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
  • Yuan Cheng
  • Xue-lei Ma
  • Yu-quan Wei
  • Xia-Wei Wei
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) 1871 (2): 289.
Tumor-Specific Induction of the Intrinsic Apoptotic Pathway—A New Therapeutic Option for Advanced Prostate Cancer?
  • Philipp Wolf
Frontiers in Oncology (2019) 9
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting
  • Peace Mabeta
International Journal of Molecular Sciences (2018) 19 (4): 1192.
Effect of TW37 on the growth of H1975 EGFR‑TKI‑resistant lung cancer cells and its underlying mechanisms
  • Jixian Liu
  • Xinhuang Yao
  • Da Wu
  • Yiwang Ye
  • Qiang Wu
  • Suyue Liu
  • Hao Wu
Molecular Medicine Reports (2017)
HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma
  • Xiang-Me Lai
  • Shu-Yu Liu
  • Yi-Ta Tsai
  • Guang-Huan Sun
  • Sun-Yran Chang
  • Shih-Ming Huang
  • Tai-Lung Cha
Oncotarget (2017) 8 (30): 49713.
Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma
  • Ying Lu
  • Haixin Huang
  • Hui Yang
  • Dagui Chen
  • Sibei Wu
  • Zhou Jiang
  • Rensheng Wang
Cell Cycle (2017) 16 (14): 1376.
Recent advances in gossypol derivatives and analogs: a chemistry and biology view
  • Yuzhi Lu
  • Jun Li
  • Chun-E Dong
  • Jian Huang
  • Hai-Bing Zhou
  • Wei Wang
Future Medicinal Chemistry (2017) 9 (11): 1243.
Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma
  • Kristy A. Warner
  • Felipe Nör
  • Gerson A. Acasigua
  • Manoela D. Martins
  • Zhaocheng Zhang
  • Scott A. McLean
  • Matthew E. Spector
  • Douglas B. Chepeha
  • Joseph Helman
  • Michael J. Wick
  • Christopher A. Moskaluk
  • Rogerio M. Castilho
  • Alexander T. Pearson
  • Shaomeng Wang
  • Jacques E. Nör
Clinical Cancer Research (2016) 22 (14): 3550.
Targeting Cell Survival Proteins for Cancer Cell Death
  • Manoj Pandey
  • Sahdeo Prasad
  • Amit Tyagi
  • Lokesh Deb
  • Jiamin Huang
  • Deepkamal Karelia
  • Shantu Amin
  • Bharat Aggarwal
Pharmaceuticals (2016) 9 (1): 11.
Physiological and Pharmacological Control of BAK, BAX, and Beyond
  • Mark P.A. Luna-Vargas
  • Jerry Edward Chipuk
Trends in Cell Biology (2016) 26 (12): 906.
Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf–DAPK Complex by Raf Inhibitor Combination Therapy
  • Yi-Ta Tsai
  • Mei-Jen Chuang
  • Shou-Hung Tang
  • Sheng-Tang Wu
  • Yu-Chi Chen
  • Guang-Huan Sun
  • Pei-Wen Hsiao
  • Shih-Ming Huang
  • Hwei-Jen Lee
  • Cheng-Ping Yu
  • Jar-Yi Ho
  • Hui-Kuan Lin
  • Ming-Rong Chen
  • Chung-Chih Lin
  • Sun-Yran Chang
  • Victor C. Lin
  • Dah-Shyong Yu
  • Tai-Lung Cha
Cancer Research (2015) 75 (17): 3568.
AT-101 inhibits hedgehog pathway activity and cancer growth
  • Juan Wang
  • Yuanqiu Peng
  • Yuan Liu
  • Jun Yang
  • Ming Huang
  • Wenfu Tan
Cancer Chemotherapy and Pharmacology (2015) 76 (3): 461.
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment
  • Cristina Correia
  • Sun-Hee Lee
  • X. Wei Meng
  • Nicole D. Vincelette
  • Katherine L.B. Knorr
  • Husheng Ding
  • Grzegorz S. Nowakowski
  • Haiming Dai
  • Scott H. Kaufmann
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2015) 1853 (7): 1658.
In Vitro and in Vivo Studies of Novel Poly(d,l-lactic acid), Superhydrophilic Carbon Nanotubes, and Nanohydroxyapatite Scaffolds for Bone Regeneration
  • Idalia A. W. B. Siqueira
  • Marcus Alexandre F. Corat
  • Bruno das Neves Cavalcanti
  • Wilson Alves Ribeiro Neto
  • Airton Abrahao Martin
  • Rosario Elida Suman Bretas
  • Fernanda Roberta Marciano
  • Anderson Oliveira Lobo
ACS Applied Materials & Interfaces (2015) 7 (18): 9385.
Cisplatin Induces Bmi-1 and Enhances the Stem Cell Fraction in Head and Neck Cancer
  • Carolina Nör
  • Zhaocheng Zhang
  • Kristy A. Warner
  • Lisiane Bernardi
  • Fernanda Visioli
  • Joseph I. Helman
  • Rafael Roesler
  • Jacques E. Nör
Neoplasia (2014) 16 (2): 137.
Glucose-Regulated Protein 78 (Grp78) Confers Chemoresistance to Tumor Endothelial Cells under Acidic Stress
  • Fernanda Visioli
  • Yugang Wang
  • Goleeta N. Alam
  • Yu Ning
  • Pantelis V. Rados
  • Jacques E. Nör
  • Peter J. Polverini
  • Yuanpu Peter Di
PLoS ONE (2014) 9 (6): e101053.
Xenograft Tumors Vascularized with Murine Blood Vessels May Overestimate the Effect of Anti-Tumor Drugs: A Pilot Study
  • Zhihong Dong
  • Atsushi Imai
  • Sudha Krishnamurthy
  • Zhaocheng Zhang
  • Benjamin D. Zeitlin
  • Jacques E. Nör
  • Joseph Alan Bauer
PLoS ONE (2013) 8 (12): e84236.
Fish on chips: Microfluidic living embryo array for accelerated in vivo angiogenesis assays
  • Jin Akagi
  • Khashayar Khoshmanesh
  • Chris J. Hall
  • Jonathan M. Cooper
  • Kathryn E. Crosier
  • Philip S. Crosier
  • Donald Wlodkowic
Sensors and Actuators B: Chemical (2013) 189: 11.
Targeting the Bcl-2 family for cancer therapy
  • Shibu Thomas
  • Bridget A Quinn
  • Swadesh K Das
  • Rupesh Dash
  • Luni Emdad
  • Santanu Dasgupta
  • Xiang-Yang Wang
  • Paul Dent
  • John C Reed
  • Maurizio Pellecchia
  • Devanand Sarkar
  • Paul B Fisher
Expert Opinion on Therapeutic Targets (2013) 17 (1): 61.
Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors
  • Jeremy L. Yap
  • Xiaobo Cao
  • Kenno Vanommeslaeghe
  • Kwan-Young Jung
  • Chander Peddaboina
  • Paul T. Wilder
  • Anjan Nan
  • Alexander D. MacKerell
  • W. Roy Smythe
  • Steven Fletcher
Organic & Biomolecular Chemistry (2012) 10 (15): 2928.
Extended survival of SH‐SY5Y cells following overexpression of Lys67Glu neuroglobin is associated with stabilization of ΔψM
  • Joanna Skommer
  • Thomas Brittain
Cytometry Part A (2012) 81A (7): 602.
Peptide screening to knockdown Bcl-2's anti-apoptotic activity: Implications in cancer treatment
  • Pawan Kumar Raghav
  • Yogesh Kumar Verma
  • Gurudutta U. Gangenahalli
International Journal of Biological Macromolecules (2012) 50 (3): 796.
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer
  • G. Sonpavde
  • V. Matveev
  • J.M. Burke
  • J.R. Caton
  • M.T. Fleming
  • T.E. Hutson
  • M.D. Galsky
  • W.R. Berry
  • P. Karlov
  • J.T. Holmlund
  • B.A. Wood
  • M. Brookes
  • L. Leopold
Annals of Oncology (2012) 23 (7): 1803.
Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells
  • Justus Lieber
  • Verena Ellerkamp
  • Julia Wenz
  • Bettina Kirchner
  • Steven W. Warmann
  • Jörg Fuchs
  • Sorin Armeanu-Ebinger
Pediatric Surgery International (2012) 28 (2): 149.
Ligand binding, reactivity and biological activity of a distal pocket mutant of neuroglobin
  • J. Skommer
  • S. Helbo
  • K. Henty
  • T. Brittain
International Journal of Biological Macromolecules (2012) 51 (3): 284.
Metronomic Dosing of BH3 Mimetic Small Molecule Yields Robust Antiangiogenic and Antitumor Effects
  • Atsushi Imai
  • Benjamin D. Zeitlin
  • Fernanda Visioli
  • Zhihong Dong
  • Zhaocheng Zhang
  • Sudha Krishnamurthy
  • Emily Light
  • Frank Worden
  • Shaomeng Wang
  • Jacques E. Nör
Cancer Research (2012) 72 (3): 716.
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review
  • Naval Bajwa
  • Chenzhong Liao
  • Zaneta Nikolovska-Coleska
Expert Opinion on Therapeutic Patents (2012) 22 (1): 37.
Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy
  • Ashiq Masood
  • Asfar S. Azmi
  • Ramzi M. Mohammad
Cancers (2011) 3 (2): 1527.
Amphipathic Tail-anchoring Peptide and Bcl-2 Homology Domain-3 (BH3) Peptides from Bcl-2 Family Proteins Induce Apoptosis through Different Mechanisms
  • Jae-Kyun Ko
  • Kyoung-Han Choi
  • Jun Peng
  • Feng He
  • Zhi Zhang
  • Noah Weisleder
  • Jialing Lin
  • Jianjie Ma
Journal of Biological Chemistry (2011) 286 (11): 9038.
Emerging Bcl-2 inhibitors for the treatment of cancer
  • Asfar S Azmi
  • Zhiwei Wang
  • Philip A Philip
  • Ramzi M Mohammad
  • Fazlul H Sarkar
Expert Opinion on Emerging Drugs (2011) 16 (1): 59.
Dual targeting of Bcl-2 and VEGF: A potential strategy to improve therapy for prostate cancer
  • Satoshi Anai
  • Noboru Sakamoto
  • Yoshihisa Sakai
  • Motoyoshi Tanaka
  • Stacy Porvasnik
  • Cydney Urbanek
  • Wengang Cao
  • Steve Goodison
  • Charles J. Rosser
Urologic Oncology: Seminars and Original Investigations (2011) 29 (4): 421.
Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer
  • Neal Ready
  • Nina A. Karaseva
  • Sergey V. Orlov
  • Alexander V. Luft
  • Olexandr Popovych
  • Jon T. Holmlund
  • Brian A. Wood
  • Lance Leopold
Journal of Thoracic Oncology (2011) 6 (4): 781.
Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells
  • D Trisciuoglio
  • C Gabellini
  • M Desideri
  • Y Ragazzoni
  • T De Luca
  • E Ziparo
  • D Del Bufalo
Cell Death & Differentiation (2011) 18 (6): 1024.
Opposing effects of bim and bcl-2 on lung endothelial cell migration
  • Cathy Grutzmacher
  • SunYoung Park
  • Tammy L. Elmergreen
  • Yixin Tang
  • Elizabeth A. Scheef
  • Nader Sheibani
  • Christine M. Sorenson
American Journal of Physiology-Lung Cellular and Molecular Physiology (2010) 299 (5): L607.
PAR-4 as a possible new target for pancreatic cancer therapy
  • Asfar S Azmi
  • Philip A Philip
  • Syed F Zafar
  • Fazlul H Sarkar
  • Ramzi M Mohammad
Expert Opinion on Therapeutic Targets (2010) 14 (6): 611.
Metronomic Small Molecule Inhibitor of Bcl-2 (TW-37) Is Antiangiogenic and Potentiates the Antitumor Effect of Ionizing Radiation
  • Benjamin D. Zeitlin
  • Aaron C. Spalding
  • Marcia S. Campos
  • Naoki Ashimori
  • Zhihong Dong
  • Shaomeng Wang
  • Theodore S. Lawrence
  • Jacques E. Nör
International Journal of Radiation Oncology*Biology*Physics (2010) 78 (3): 879.
Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer
  • Rebecca Suk Heist
  • Jerry Fain
  • Bernard Chinnasami
  • Waseem Khan
  • Julian R. Molina
  • Lecia V. Sequist
  • Jennifer S. Temel
  • Panos Fidias
  • Valari Brainerd
  • Lance Leopold
  • Thomas J. Lynch
Journal of Thoracic Oncology (2010) 5 (10): 1637.
Quantification of endothelial cell–targeted anti–Bcl-2 therapy and its suppression of tumor growth and vascularization
  • Harsh Vardhan Jain
  • Jacques Eduardo Nör
  • Trachette Levon Jackson
Molecular Cancer Therapeutics (2009) 8 (10): 2926.
TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway
  • Zhiwei Wang
  • Asfar Sohail Azmi
  • Aamir Ahmad
  • Sanjeev Banerjee
  • Shaomeng Wang
  • Fazlul H. Sarkar
  • Ramzi M. Mohammad
Cancer Research (2009) 69 (7): 2757.
Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non–Small Cell Lung Tumor Xenograft Model
  • Kwang Woon Kim
  • Luigi Moretti
  • Lauren Rhea Mitchell
  • Dae Kwang Jung
  • Bo Lu
Clinical Cancer Research (2009) 15 (19): 6096.
TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis
  • Naoki Ashimori
  • Benjamin D. Zeitlin
  • Zhaocheng Zhang
  • Kristy Warner
  • Ilan M. Turkienicz
  • Aaron C. Spalding
  • Theodoros N. Teknos
  • Shaomeng Wang
  • Jacques E. Nör
Molecular Cancer Therapeutics (2009) 8 (4): 893.
VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model
  • Yoshihisa Sakai
  • Steve Goodison
  • Wengang Cao
  • Virginia Urquidi
  • Kazunori Namiki
  • Stacy Porvasnik
  • Cydney Urbanek
  • Charles Joel Rosser
World Journal of Urology (2009) 27 (5): 659.
VEGF and Bcl-2 Interact Via MAPKs Signaling Pathway in the Response to Hypoxia in Neuroblastoma
  • Duoduo Wang
  • Qinjie Weng
  • Lei Zhang
  • Qiaojun He
  • Bo Yang
Cellular and Molecular Neurobiology (2009) 29 (3): 391.
Non‐peptidic small molecule inhibitors against Bcl‐2 for cancer therapy
  • Asfar S. Azmi
  • Ramzi M. Mohammad
Journal of Cellular Physiology (2009) 218 (1): 13.
  • Online ISSN 1538-7445
  • Print ISSN 0008-5472

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept